$180.23
1.90% today
NYSE, Aug 22, 10:00 pm CET
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Stock price

$180.23
+1.99 1.12% 1M
+6.17 3.54% 6M
+29.37 19.47% YTD
+27.39 17.92% 1Y
+48.24 36.55% 3Y
+62.63 53.26% 5Y
+112.92 167.76% 10Y
+130.08 259.38% 20Y
NYSE, Closing price Fri, Aug 22 2025
-3.49 1.90%

Key metrics

Basic
Market capitalization
$20.5b
Enterprise Value
$25.9b
Net debt
$5.4b
Cash
$319.0m
Shares outstanding
112.0m
Valuation (TTM | estimate)
P/E
21.9 | 18.8
P/S
2.0 | 1.9
EV/Sales
2.5 | 2.4
EV/FCF
21.2
P/B
2.8
Dividends
DPS
$3.00
Yield 1Y | 5Y
1.6% | 2.0%
Growth 1Y | 5Y
5.6% | 7.2%
Payout 1Y | 3Y
39.2% | 36.6%
Increased
14 Years
Financials (TTM | estimate)
Revenue
$10.5b | $10.9b
EBITDA
$1.7b | $2.2b
EBIT
$1.5b | $1.7b
Net Income
$946.0m | $1.1b
Free Cash Flow
$1.2b
Growth (TTM | estimate)
Revenue
12.6% | 10.9%
EBITDA
18.4% | 42.6%
EBIT
17.3% | 23.9%
Net Income
13.2% | 26.7%
Free Cash Flow
39.9%
Margin (TTM | estimate)
Gross
33.2%
EBITDA
16.1% | 20.0%
EBIT
14.7%
Net
9.0% | 10.0%
Free Cash Flow
11.6%
Financial Health
Equity Ratio
42.0%
Return on Equity
12.8%
ROCE
11.1%
ROIC
-
Debt/Equity
0.8
More
EPS
$8.4
FCF per Share
$10.9
Short interest
4.8%
Employees
51k
Rev per Employee
$200.0k
Show more

Is Quest Diagnostics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Quest Diagnostics Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Quest Diagnostics forecast:

13x Buy
54%
11x Hold
46%

Analyst Opinions

24 Analysts have issued a Quest Diagnostics forecast:

Buy
54%
Hold
46%

Financial data from Quest Diagnostics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
10,522 10,522
13% 13%
100%
- Direct Costs 7,026 7,026
12% 12%
67%
3,496 3,496
13% 13%
33%
- Selling and Administrative Expenses 1,844 1,844
13% 13%
18%
- Research and Development Expense - -
-
-
1,694 1,694
18% 18%
16%
- Depreciation and Amortization 147 147
31% 31%
1%
EBIT (Operating Income) EBIT 1,547 1,547
17% 17%
15%
Net Profit 946 946
13% 13%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Quest Diagnostics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quest Diagnostics Stock News

Neutral
PRNewsWire
7 days ago
SECAUCUS, N.J. , Aug. 15, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during the Baird 2025 Global Healthcare Conference in New York City on Wednesday, September 10, 2025, at 10:50...
Neutral
PRNewsWire
9 days ago
SECAUCUS, N.J. , Aug. 13, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.80 per share, payable on October 20, 2025 to shareholders of record of Quest Diagnostics common stock on October 3, 2025.
Neutral
PRNewsWire
15 days ago
SECAUCUS, N.J. and BOSTON , Aug. 7, 2025 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, today announced a research collaboration with Mass General Brigham investigators at Massachusetts Eye and Ear and Massachusetts General Hospital, world-renowned centers for head and neck and advanced cutaneous oncology.
More Quest Diagnostics News

Company Profile

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Head office United States
CEO James Davis
Employees 50,500
Founded 1967
Website www.questdiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today